Papillary renal cell carcinoma (pRCC) is a heterogeneous kidney tumor with diverse molecular drivers. Metastatic pRCC is poorly understood and treated with antiangiogenic agents and immunotherapy lacking biological rationale, resulting in suboptimal outcomes and highlighting the need for personalized treatment strategies. The pRCC-TREAT project is an international collaboration funded by EP PerMed (Spain, Italy, France, Germany).
The consortium will perform multi-omic characterization of metastatic pRCC samples across four European countries, integrating real-world drug response data with preclinical model testing to create the world’s largest metastatic pRCC database. Heidelberg University leads WP4 (Multidimensional Data Integration), focusing on centralized data management and machine learning-based integration of multi-omic datasets. WP4 will identify predictive signatures and develop treatment response models to enable biomarker-guided clinical trials. You can find a brief description of the overall project here
As a postdoctoral researcher in WP4 (Multidimensional Data Integration), you will:
Application until 15/02/2026
Upload CV, cover letter addressed to Prof. Dr. Carl Herrmann, and contact information for 2-3 references in a single pdf file indicating your name using this upload link
Heidelberg University stands for equal opportunities and diversity.